Upstream Bio (UPB) Share-based Compensation (2023 - 2026)

Upstream Bio's Share-based Compensation history runs 4 years deep, the most recent figure standing at $43.4 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 1547.06% year-over-year to $43.4 million; the TTM figure through Mar 2026 stood at $43.4 million (up 442.77% YoY), while the FY2025 annual figure was $21.4 million, up 37.18% from the prior year.
• Share-based Compensation for Q1 2026 stood at $43.4 million, up from -$7.8 million in the prior quarter.
• The five-year high for Share-based Compensation was $43.4 million in Q1 2026, with the low at -$7.8 million in Q4 2025.
• The 4-year median for Share-based Compensation is $1.9 million (2024), against an average of $8.5 million.
• Peak annual rise in Share-based Compensation reached 1628.05% in 2025, while the deepest fall reached 475.17% in 2025.
• Upstream Bio's Share-based Compensation stood at $711000.0 in 2023, then soared by 193.39% to $2.1 million in 2024, then plunged by 475.17% to -$7.8 million in 2025, then soared by 654.56% to $43.4 million in 2026.
• Business Quant data shows UPB's Share-based Compensation at $43.4 million in Q1 2026, -$7.8 million in Q4 2025, and $23.0 million in Q3 2025.